Business Wire

Mavenir Leads an Open RAN Ecosystem

Jaa

Mavenir, focused on transforming mobile network economics for communications service providers (CSPs), is announcing an Open RAN partner ecosystem that provides more options and makes it easy for operators to deploy an innovative, flexible Cloud-based Open RAN solution. Mavenir will act as the End-to-End systems integrator simplifying the engagement for operators and creating an offering that is on par with the traditional, hardware centric proprietary vendors.

Ecosystem partners include MTI, Tecore Networks, Baicells, NEC, AceAxis, KMW, Benetel, CommScope, Blue Danube Systems and Airrays.

“Mavenir has always been extremely active in promoting open interfaces as we believe it is in the interest of the CSPs and the overall industry. We will continue to support any effort in the direction of cloud-based architectures and virtualized solutions,” said Pardeep Kohli, President and CEO of Mavenir. “The formation of this ecosystem essentially creates a challenger to the traditional radio vendors. Mavenir would like to encourage any other player to support this effort which will result in a significant disruptive game changer as operators continue to seek a new economic model in a world where a traditional, hardware-based approach is no longer a viable option.”

“This Open RAN ecosystem announcement expands the addressable market for Open RAN solutions,” said Daryl Schoolar, Practice Leader, Service Provider Infrastructure and Software at Ovum. “The ecosystem partners allow for addressing a greater variety of deployment scenarios. End-to-end solution integration makes it easier for smaller operators to deploy these solutions as Mavenir will take on the responsibility of interoperability testing and multi-vendor integration. Smaller operators can lack the internal resources to deploy and manage a multi-vendor network.”

“Global mobile transformation is being defined by 5G, IOT, and subscriber demand for exponential capacity driving new economics and ecosystems, as a partner with Mavenir we are excited to be at the forefront driving a software and open ecosystem,” said Mark Pinto, CEO of Blue Danube.

“The xRAN interoperability testing between Baicells and Mavenir proves that the future of 5G has arrived,” said Minchul Ho, Vice-President of Vertical Sales, Baicells. “The Cloud RAN architecture provides operators several benefits including reduced opex from maintenance, economies of scale efficiencies and vast improved performance due to greater coordination among cells.”

“Achieving seamless Interoperability whilst providing a high level of system flexibility presents a significant challenge to both the RRU vendor and CSP community alike,” said Adrian O’Connor, CEO of Benetel. “However, with the help of these disruptive ecosystem partners and leaders like Mavenir, we will realize an end to end solution in the coming months.”

Interoperability testing has already been conducted based on the xRAN Option 7.2 split specification. Recently, the full xRAN (now ORAN) specifications have been officially released containing the management plane (M-plane), for which Mavenir significantly contributed, making this a complete open specification. Mavenir continues to test the latest version of the Option 7.2 split with the ecosystem partners, who are committed to the Open RAN community and making their solutions commercially available.

This approach is now being favored by Operators who want to embrace Open RAN as it allows the deployment of open market (whitebox) remote radio unit (RRUs) to interwork with the virtualized cloud base band unit (vBBU) over ethernet fronthaul (FH). With this, CSPs can break the stranglehold of closed proprietary specifications and the need to implement dark fiber for RRU fronthaul, which could pose significant economical burdens in some countries. They can continue to provide fronthaul and backhaul in the traditional ways like microwaves and IP/MPLS technologies.

About Mavenir:

Mavenir is purpose-built to redefine mobile network economics for Communication Service Providers (CSPs). Our innovative solutions pave the way to 5G with 100% software-based, end-to-end, Cloud Native network solutions. Leveraging industry-leading firsts in VoLTE, VoWiFi, Advanced Messaging (RCS), Multi-ID, vEPC and Cloud RAN, Mavenir accelerates network transformation for more than 250+ CSP customers in over 130 countries, serving over 50% of the world’s subscribers.

We embrace disruptive, innovative technology architectures and business models that drive service agility, flexibility, and velocity. With solutions that propel NFV evolution to achieve web-scale economics, Mavenir offers solutions to help CSPs with cost reduction, revenue generation and revenue protection. Learn more at mavenir.com.

Mavenir, the M logo, and Cloud Range are trademarks owned by Mavenir Systems, Inc.

Copyright © 2018 Mavenir Systems, Inc. All Rights Reserved.

Contact information

Mavenir
Maryvonne Tubb
PR@mavenir.com
or
MatterNow
Lydia Fakhouri
mavenir@matternow.com
or
GlobalResultsPR
Kevin Taylor
mavenir@globalresultspr.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 13:49Tiedote

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme